Cerco Medical Team


Scott R. King

Presidentand CEO of the Company and one of its founders. He received a B.S. in Chemistry from the University of Chicago in 1977 and an M.A. in Biochemistry from Harvard University in 1978. He was an investment analyst specializing in biological and medical technology at F. Eberstadt & Co. in New York and Montgomery Securities in San Francisco from 1979 to 1986. He wrote Wall Street's first investment report on the diabetes industry. He was diagnosed with type 1 diabetes in 1978, and has sought a cure ever since. He has more than 35 years of experience in diabetes research including previous ventures in the islet transplantation field, including Transtech Medical and Metabolex. He is also President of Hanuman Medical LLC and PlasmaSeal LLC. (Click here for Scott's C.V.)

Randy Dorian

Randy Dorian, age 55, is the Senior Vice President and Chief Science Officer of Research of the Company and one of its founders. He has 35 years of experience in academic and industrial research and development. He received a B.S. in Biochemistry from the University of California at San Diego in 1975 and was awarded an honorary Doctorate in Aerospace Medicine (AMD) by the U.S. Air Force Systems Command, Aerospace Medical Division, for his pioneering work in genetic manipulation. He was Director of Research and Development of Babagene, Inc. (1985-1987) and Senior Scientist in charge of Cell Isolation Technology at Bio Response, Inc. (1981-1985), Senior Scientist and Director of Process Development at Transtech Medical (1991-1994). He is skilled in biotechnology, biochemistry, applied mathematics and bioengineering design and fabrication. He has a proven ability to figure out solutions to complex biological problems and reduce inventions to practice quickly. (Click here for Randy's C.V.)


Rick Storrs

Richard W. Storrs, 46, is Vice President of Research at Cerco Medical. He received his B.A. in Chemistry from Amherst College Magna cum Laude in 1984 and a Ph.D. in Biophysical Chemistry from UC Berkeley in 1992. While at Stanford University School of Medicine he was awarded an NRSA fellowship from the NIH for non-invasive detection of apoptosis. From there he joined DepoTech Corp., now Pacira, where he headed their hemostasis and anti-inflammatory programs. This corporate experience imbued an appreciation for regulatory and quality assurance aspects of the industry. He is a highly capable, versatile pair of hands, co-inventor of the sheet fabrication methods, and all-around operations guy. His passion is adventure travel to unlikely parts of the globe.
(Click here for Rick's C.V.)